This APA Analyst Is No Longer Bearish; Here Are Top 2 Upgrades For Monday

APA Corporation +1.67%
MoonLake Immunotherapeutics Class A +5.08%

APA Corporation

APA

42.04

+1.67%

MoonLake Immunotherapeutics Class A

MLTX

17.36

+5.08%

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Barclays analyst Betty Jiang upgraded APA Corporation (NASDAQ:APA) from Underweight to Equal-Weight and announced a $35 price target. APA shares closed at $39.11 on Friday. See how other analysts view this stock.
  • Wolfe Research analyst Andy Chen upgraded MoonLake Immunotherapeutics (NASDAQ:MLTX) from Underperform to Outperform and raised the price target from $12 to $24. MoonLake shares closed at $16.27 on Friday. See how other analysts view this stock.

Considering buying APA stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.